{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:47:24Z","timestamp":1792586844329,"version":"4.5.0"},"reference-count":15,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70016","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:01:58Z","timestamp":1782255718000},"source":"Crossref","is-referenced-by-count":0,"title":["Profiling Epidermal Growth Factor Receptor DNA Mutations In Circulating Rare Cells Using A Cell Isolation System And Droplet Digital PCR"],"prefix":"10.3791","author":[{"given":"Yoon-Tae","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Perike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Corner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Dreskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa2502929","type":"journal-article","article-title":"First-line camizestrant for emerging ESR1-mutated advanced breast cancer","volume":"393","author":"Bidard","year":"2025","unstructured":"Bidard, F. C. et al. First-line camizestrant for emerging ESR1-mutated advanced breast cancer. N Engl J Med. 393 (6), 569-580 (2025).","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.21037\/jtd.2018.12.80","type":"journal-article","article-title":"Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies","volume":"11","author":"Pawlikowska","year":"2019","unstructured":"Pawlikowska, P. et al. Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies. J Thorac Dis. 11 (Suppl 1), S45-S56 (2019).","journal-title":"J Thorac Dis"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3892\/ol.2025.15121","type":"journal-article","article-title":"EGFR mutations in non-small cell lung cancer: Classification, characteristics and resistance to third-generation EGFR-tyrosine kinase inhibitors (Review)","volume":"30","author":"Tian","year":"2025","unstructured":"Tian, Z. et al. EGFR mutations in non-small cell lung cancer: Classification, characteristics and resistance to third-generation EGFR-tyrosine kinase inhibitors (Review). Oncol Lett. 30 (2), 375 (2025).","journal-title":"Oncol Lett"},{"key":"ref4","type":"book","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer","author":"Riely","year":"2026","unstructured":"Riely, G. J. et al. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. Version 5.2026. National Comprehensive Cancer Network (2026). Available at: https:\/\/www.nccn.org (2026)."},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"e0147400","DOI":"10.1371\/journal.pone.0147400","type":"journal-article","article-title":"Development of an automated and sensitive microfluidic device for capturing and characterizing circulating tumor cells (CTCs) from clinical blood samples","volume":"11","author":"Gogoi","year":"2016","unstructured":"Gogoi, P. et al. Development of an automated and sensitive microfluidic device for capturing and characterizing circulating tumor cells (CTCs) from clinical blood samples. PLoS One. 11 (1), e0147400 (2016).","journal-title":"PLoS One"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.7150\/thno.19686","type":"journal-article","article-title":"Label-free rapid viable enrichment of circulating tumor cell by photosensitive polymer-based microfilter device","volume":"7","author":"Kang","year":"2017","unstructured":"Kang, Y. T. et al. Label-free rapid viable enrichment of circulating tumor cell by photosensitive polymer-based microfilter device. Theranostics. 7 (13), 3179-3191 (2017).","journal-title":"Theranostics"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/jcp.13.5.414","type":"journal-article","article-title":"The differential diagnosis of tumour cells in circulating blood","volume":"13","author":"Alexander","year":"1960","unstructured":"Alexander, R. F., Spriggs, A. I. The differential diagnosis of tumour cells in circulating blood. J Clin Pathol. 13 (5), 414-424 (1960).","journal-title":"J Clin Pathol"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","type":"journal-article","article-title":"Circulating tumour cells in cancer patients: Challenges and perspectives","volume":"16","author":"Pantel","year":"2010","unstructured":"Pantel, K., Alix-Panabi\u00e8res, C. Circulating tumour cells in cancer patients: Challenges and perspectives. Trends Mol Med. 16 (9), 398-406 (2010).","journal-title":"Trends Mol Med"},{"issue":"20","key":"ref9","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","type":"journal-article","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","unstructured":"Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 10 (20), 6897-6904 (2004).","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/ijms23041981","type":"journal-article","article-title":"Microfluidic-based technologies for CTC isolation: A review of 10 years of intense efforts towards liquid biopsy","volume":"23","author":"Descamps","year":"2022","unstructured":"Descamps, L., Le Roy, D., Deman, A. L. Microfluidic-based technologies for CTC isolation: A review of 10 years of intense efforts towards liquid biopsy. Int J Mol Sci. 23 (4), 1981 (2022).","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/cancers13050970","type":"journal-article","article-title":"A review of circulating tumour cell enrichment technologies","volume":"13","author":"Rushton","year":"2021","unstructured":"Rushton, A. J., Nteliopoulos, G., Shaw, J. A., Coombes, R. C. A review of circulating tumour cell enrichment technologies. Cancers (Basel). 13 (5), 970 (2021).","journal-title":"Cancers (Basel)"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cyto.a.23669","type":"journal-article","article-title":"Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting","volume":"93","author":"Fehm","year":"2018","unstructured":"Fehm, T. N. et al. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting. Cytometry A. 93 (12), 1213-1219 (2018).","journal-title":"Cytometry A"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/cancers15061877","type":"journal-article","article-title":"Preoperative mutational analysis of circulating tumor cells (CTCs) and plasma-cfDNA provides complementary information for early prediction of relapse: A pilot study in early-stage non-small cell lung cancer","volume":"15","author":"Markou","year":"2023","unstructured":"Markou, A. N. et al. Preoperative mutational analysis of circulating tumor cells (CTCs) and plasma-cfDNA provides complementary information for early prediction of relapse: A pilot study in early-stage non-small cell lung cancer. Cancers (Basel). 15 (6), 1877 (2023).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/1878-0261.13787","type":"journal-article","article-title":"Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR","volume":"19","author":"Smilkou","year":"2025","unstructured":"Smilkou, S. et al. Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR. Mol Oncol. 19 (7), 2109-2119 (2025).","journal-title":"Mol Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2020.07.014","type":"journal-article","article-title":"Mechanisms of osimertinib resistance and emerging treatment options","volume":"147","author":"Schmid","year":"2020","unstructured":"Schmid, S., Li, J. J. N., Leighl, N. B. Mechanisms of osimertinib resistance and emerging treatment options. Lung Cancer. 147, 123-129 (2020).","journal-title":"Lung Cancer"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70016\/profiling-epidermal-growth-factor-receptor-dna-mutations-circulating","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:27:26Z","timestamp":1792585646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70016\/profiling-epidermal-growth-factor-receptor-dna-mutations-circulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":15,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70016","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}